Longer-term outcomes of paclitaxel stent implantation as an initial treatment strategy for sirolimus-eluting stent restenosis

Journal of Invasive Cardiology

Volumn 22, Issue 5, 2010, Pages 216-219

  Levisay, Justin P ^a   Price, Matthew J ^b   Shaba, Wisam ^b   Lee, Steve S ^b   Stinis, Curtiss P ^b   Miller, Latrice ^c   Teirstein, Paul S ^b  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^b SCRIPPS CLINIC   (United States)

^c NONE

Author keywords

drug elutings stents; target lesion revascularization

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBIN; CLOPIDOGREL; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; PACLITAXEL; RAPAMYCIN; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; CORONARY ARTERY THROMBOSIS; CORONARY STENT; DRUG ELUTING STENT; DRUG SAFETY; FEMALE; FOLLOW UP; HEART DISEASE; HEART INFARCTION; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEOPLASM; PACLITAXEL ELUTING STENT; RECURRENT DISEASE; RESTENOSIS; REVASCULARIZATION; SEPSIS; SIROLIMUS ELUTING STENT; STENT THROMBOSIS; TREATMENT OUTCOME; ANGIOCARDIOGRAPHY; CORONARY ARTERY DISEASE; DISEASE FREE SURVIVAL; DRUG RESISTANCE; MIDDLE AGED; PREDICTION AND FORECASTING; RADIOGRAPHY; RETREATMENT; STATISTICS; SURVIVAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DISEASE-FREE SURVIVAL; DRUG RESISTANCE; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; PREDICTIVE VALUE OF TESTS; RETREATMENT; SIROLIMUS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 77954622024     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Stone GW, Ellis SG, Cannon L, et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: A randomized controlled trial. JAMA 2005;294:1215-1223.
2. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323.
3. Beohar DC, Kip KE, Goodreau L, et al. Outcomes and complications associated with off-label use and untested use of drug-eluting stents. JAMA 2000;2007:1992-2000.
4. Mauri L HW, Massaro JM, Ho KK, et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007;356:1020-1029.
5. Mehran R, Dangas G, Abizaid AS, et al. Angiographic patterns of in-stent restenosis: Classification and implications for long-term outcome. Circulation 1999;100:1872-1878.
6. Cosgrave J, Melzi G, Corbett S, et al. Repeated drug-eluting stent implantation for drugeluting stent restenosis: The same or a different stent. Am Heart J 2007;153:354-359.
7. Colombo A, Orlic D, Stankovic G, et al. Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation. Circulation 2003;107:2178-2180.
8. Lee SS, Price MJ, Wong GB, et al. Early- and medium-term outcomes after paclitaxeleluting stent implantation for sirolimus-eluting stent failure. Am J Cardiol 2006;98:1345-1348.
9. Cosgrave J, Agostoni P, Ge L, et al. Clinical outcome following aleatory implantation of paclitaxel-eluting or sirolimus-eluting stents in complex coronary lesions. Am J Cardiol 2005;96:1663-1668.
10. Glaser R SF, Jacobs AK, Laskey WK, et al. Effect of gender on prognosis following percutaneous coronary intervention for stable angina pectoris and acute coronary syndromes. Am J Cardiol 2006;98:1446-1450.
11. Di Mario C MN, Godino C, Goktekin O, et al. Predictors of restenosis after treatment of bifurcation lesions with paclitaxel eluting stents: A multicenter prospective registry of 150 consecutive patients. Catheter Cardiovasc Interv 2007;69:416-424.
12. Yanagi D SK, Mori K, Ike A, et al. Possible predictors of target lesion revascularization after drug-eluting stent implantation. J Cardiol 2007;49:63-67.
13. Kastrati A, Dibra A, Eberle S, et al. Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: Meta-analysis of randomized trials. JAMA 2005;294:819-825.
14. Huang S, Houghton PJ. Mechanisms of resistance to rapamycins. Drug Resist Updat 2001;4:378-391.
15. Richardson A KS. Drug resistance in ovarian cancer: The emerging importance of gene transcription and spatio-temporal regulation of resistance. Drug Resist Updat 2005;8:311-321.
16. Mishkel GJ, Moore AL, Markwell S, et al. Long-term outcomes after management of restenosis or thrombosis of drug-eluting stents. J Am Coll Cardiol 2007;49:181-184.